Cargando…
349. Diagnostic Testing and Antibiotic Utilization in Patients with COVID-19
BACKGROUND: Patients with COVID-19 receive high rates of antibiotic therapy, despite viral origin of infection. Reports of bacterial coinfection range from 3.5 to 8% in the early phase of infection. This study aimed to evaluate the relationship between diagnostic tests and antibiotic utilization in...
Autores principales: | Groft, Lauren, Opran, Iulia, Tadesse, Yeabsera, Vo, Hang, Heil, Emily, Schrank, Gregory, Claeys, Kimberly C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643796/ http://dx.doi.org/10.1093/ofid/ofab466.550 |
Ejemplares similares
-
1220. Is MIC all that matters? MIC Distributions of Ceftazidime and Cefepime in Ceftriaxone-Resistant E. coli and Klebsiella spp
por: Heil, Emily, et al.
Publicado: (2021) -
1024. Using DOOR-MAT to Theoretically Compare Three Rapid Diagnostic Tests for Gram-Negative Bloodstream Infections in Immunocompromised Patients
por: Groft, Lauren, et al.
Publicado: (2021) -
274. Comparison of Cefazolin Susceptibilities of Enterobacterales with an Automated Susceptibility Testing Platform versus In Vitro Antimicrobial Testing
por: Noval, Mandee, et al.
Publicado: (2020) -
2362. Emergency Department Resource Utilization After Implementation of a Dalbavancin Pathway for Skin and Soft-Tissue Infections
por: Heil, Emily, et al.
Publicado: (2018) -
Effectiveness of 8 or 12 Week Treatment Duration of Ledipasvir/Sofosbuvir for Hepatitis C: Evidence from a Large Academic Medical Center
por: Vega, Ana, et al.
Publicado: (2017)